Novartis Bioventures Ltd sold $1.1M of Ra Pharmaceuticals, Inc.

10% owner

Sold$1,107,073

$23.93Price

46,261Shares

−2%Stake

What RARX did after the filing

Prices for RARX after this filing aren't in yet.

Traded Wed, May 31. Filed Fri, Jun 2, 12:25 PM ET, during the session. Not investment advice.